carvedilol has been researched along with Glomerulosclerosis, Focal Segmental in 2 studies
Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, DP | 1 |
| Short, BG | 1 |
| Cyronak, MJ | 1 |
| Contino, LC | 1 |
| DiCristo, M | 1 |
| Wang, YX | 1 |
| Ruffolo, RR | 1 |
| Van den Branden, C | 1 |
| Gabriels, M | 1 |
| Vamecq, J | 1 |
| Vanden Houte, K | 1 |
| Verbeelen, D | 1 |
2 other studies available for carvedilol and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Blood Urea Nitrogen; Captopril; Carbazoles; Ca | 1993 |
Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.
Topics: Adrenergic beta-Antagonists; Aldehydes; Animals; Antioxidants; Blood Pressure; Carbazoles; Carvedilo | 1997 |